68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery

NCT02678351 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Stage II Prostate Adenocarcinoma
Stage III Prostate Adenocarcinoma

Interventions

DRUG: 68Ga-PSMA-11
PROCEDURE: Magnetic resonance imaging (MRI)
PROCEDURE: Positron Emission Tomography (PET)

Sponsor

Andrei Iagaru

Collaborators

[object Object]